Please login to the form below

Not currently logged in
Email:
Password:

PAN appoints Sarah Verhoeff as an associate director

Formerly with Euro RSCG Life (now Havas Life) in US and UK

Sarah_Verhoeff_PANSarah Vernhoeff has joined PAN as an associate director. She will report to client services director Emily Wigginton.

Vernhoeff was most recently business director at the UK office of Euro RSCG Life as it was then known, having transferred from its New York office.

She has also worked for Metamax, Rapp Collins Healthcare and McCann Relationship Marketing and was educated at University of Pennsylvania.

Jon Linscott, managing director of PAN said: “Sarah is a senior brand consultancy specialist with a proven track record for leading agency teams across multiple client businesses. We are delighted to welcome her to PAN at an exciting time in the company's development.”

Verhoeff commented: “With more than a decade's experience of healthcare marketing, both in the UK and the US, I am looking forward to working with the senior team at PAN to develop its business.”

Part of the marketing services group, Creston, London-based PAN is a founding member of the Indigenus global network. Describing itself as being about 'influential creativity', PAN won Highly Commended at the recent PM Society Advertising Awards in the Digital Sales Aid category for its Avamys campaign for GlaxoSmithKline.

12th February 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics